7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
The DOI matches its Crossref record; 224 of the 225 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, for some individuals, glucose monitoring can provide insight into the impact of lifestyle and medication management on blood glucose and symptoms, particularly when combined with education and support (53).”
In the citing paper
“Technologies such as intermittently scanned or real-time continuous glucose monitoring (CGM) provide more information and may be useful for people with type 2 diabetes, particularly in those treated with insulin (53,56).”
In the citing paper
“Professional CGM, along with professional interpretation, patient education, and therapy adjustments, may help reduce hyper-and/or hypoglycemia, but rigorous data are lacking (105).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [105]
In the citing paper
“Consequently, both guidelines emphasize the concurrent use of 1) HbA1c as a metric upon which therapeutic targets are defined based on randomized controlled trial (RCT) data, 2) continuous glucose monitoring (CGM) to assess effectiveness and safety of treatment among patients at risk for hypoglycemia or to assess overall glycemia when HbA1c is inaccurate, and 3) self-monitoring of blood glucose as”
In the citing paper
“The ADA and KDIGO guidelines highlight the important role of CGM technology in improving diabetes management as a tool to identify and correct glycemic derangements, prevent hypoglycemia, direct medication management, and guide medical nutritional therapy and physical activity, as well as its rapid evolution in affordability and accuracy (2,37) (Supplementary Table 1).”
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · cited 1×
“A variety of metrics have been proposed (80) and are discussed in Section 6, “Glycemic Targets” (https://doi .”
BackgroundContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185 · cited 1×
“The primary outcome was met and showed benefit in adults of all ages (30,40,41,46,47, 49,51,52) including seniors (48).”
BackgroundInternational Standards Organization
(2010) · Encyclopedia of Nanoscience and Society · doi:10.4135/9781412972093.n191 · Cited by 1,071
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Feig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32400-5 · Cited by 803
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., et al. (2017) · JAMA · doi:10.1001/jama.2016.19976 · Cited by 705
Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635
Haak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623
Parkes, J. L., Slatin, S. L., Pardo, S., & Ginsberg, B. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1143 · Cited by 620
Pickup, J. C., & Sutton, A. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02486.x · Cited by 617
Garg, S. K., Weinzimer, S. A., Tamborlane, W. V., Buckingham, B. A., Bode, B. W., Bailey, T. S., Brazg, R. L., Ilany, J., Slover, R. H., Anderson, S. M., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0421 · Cited by 585
Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., et al. (2021) · JAMA · doi:10.1001/jama.2021.7444 · Cited by 543
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Heinemann, L., Freckmann, G., Ehrmann, D., Faber-Heinemann, G., Guerra, S., Waldenmaier, D., & Hermanns, N. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30297-6 · Cited by 522
Miller, K. M., Beck, R. W., Bergenstal, R. M., Goland, R. S., Haller, M. J., McGill, J. B., Rodriguez, H., Simmons, J. H., Hirsch, I. B., & for the T1D Exchange Clinic Network (2013) · Diabetes Care · doi:10.2337/dc12-1770 · Cited by 505
the SWITCH Study Group, Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., & Bolinder, J. (2012) · Diabetologia · doi:10.1007/s00125-012-2708-9 · Cited by 494
Yeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493 · cited 1×
“02]) and for reducing severe hypoglycemia rates in children and adults (133).”
BackgroundEffect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
Battelino, T., Phillip, M., Bratina, N., Nimri, R., Oskarsson, P., & Bolinder, J. (2011) · Diabetes Care · doi:10.2337/dc10-1989 · Cited by 490
Karges, B., Schwandt, A., Heidtmann, B., Kordonouri, O., Binder, E., Schierloh, U., Boettcher, C., Kapellen, T., Rosenbauer, J., & Holl, R. W. (2017) · JAMA · doi:10.1001/jama.2017.13994 · Cited by 452 · cited 1×
“There is also evidence that CSII may reduce DKA risk (155,160) and diabetes”
BackgroundRosenstock, J., Davies, M., Home, P. D., Larsen, J., Koenen, C., & Schernthaner, G. (2008) · Diabetologia · doi:10.1007/s00125-007-0911-x · Cited by 447
Laffel, L. M., Kanapka, L. G., Beck, R. W., Bergamo, K., Clements, M. A., Criego, A., DeSalvo, D. J., Goland, R., Hood, K., Liljenquist, D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6940 · Cited by 443
Tauschmann, M., Thabit, H., Bally, L., Allen, J. M., Hartnell, S., Wilinska, M. E., Ruan, Y., Sibayan, J., Kollman, C., Cheng, P., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31947-0 · Cited by 440
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S. (2011) · Diabetes Care · doi:10.2337/dc10-1732 · Cited by 429
Farmer, A., Wade, A., Goyder, E., Yudkin, P., French, D., Craven, A., Holman, R., Kinmonth, A.-L., & Neil, A. (2007) · BMJ · doi:10.1136/bmj.39247.447431.be · Cited by 407
The effect of continuous glucose monitoring in well-controlled type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0108 · Cited by 399
van Beers, C. A. J., DeVries, J. H., Kleijer, S. J., Smits, M. M., Geelhoed-Duijvestijn, P. H., Kramer, M. H. H., Diamant, M., Snoek, F. J., & Serné, E. H. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30193-0 · Cited by 386 · cited 1×
“The primary outcome was met and showed benefit in adults of all ages (30,40,41,46,47, 49,51,52) including seniors (48).”
BackgroundJeitler, K., Horvath, K., Berghold, A., Gratzer, T. W., Neeser, K., Pieber, T. R., & Siebenhofer, A. (2008) · Diabetologia · doi:10.1007/s00125-008-0974-3 · Cited by 375
Pratley, R. E., Kanapka, L. G., Rickels, M. R., Ahmann, A., Aleppo, G., Beck, R., Bhargava, A., Bode, B. W., Carlson, A., Chaytor, N. S., et al. (2020) · JAMA · doi:10.1001/jama.2020.6928 · Cited by 375
Doyle (Boland), E. A., Weinzimer, S. A., Steffen, A. T., Ahern, J. A. H., Vincent, M., & Tamborlane, W. V. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1554 · Cited by 373 · cited 15×
“CSII, or insulin pumps, have been available in the U.S. for over 40 years.”
BackgroundInfluentialRacial-ethnic disparities in management and outcomes among children with type 1 diabetes
Willi, S. M., Miller, K. M., DiMeglio, L. A., Klingensmith, G. J., Simmons, J. H., Tamborlane, W. V., Nadeau, K. J., Kittelsrud, J. M., Huckfeldt, P., Beck, R. W., et al. (2015) · Pediatrics · doi:10.1542/peds.2014-1774 · Cited by 367
Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin
Malanda, U. L., Welschen, L. M., Riphagen, I. I., Dekker, J. M., Nijpels, G., & Bot, S. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005060.pub3 · Cited by 358
Factors affecting blood glucose monitoring: sources of errors in measurement
Ginsberg, B. H. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300438 · Cited by 348
Ziegler, R., Heidtmann, B., Hilgard, D., Hofer, S., Rosenbauer, J., Holl, R., & DPV-Wiss-Initiative, F. T. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00650.x · Cited by 334
Aleppo, G., Ruedy, K. J., Riddlesworth, T. D., Kruger, D. F., Peters, A. L., Hirsch, I., Bergenstal, R. M., Toschi, E., Ahmann, A. J., Shah, V. N., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2482 · Cited by 329
O’Kane, M. J., Bunting, B., Copeland, M., & Coates, V. E. (2008) · BMJ · doi:10.1136/bmj.39534.571644.be · Cited by 326
Fleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020) · Diabetes Care · doi:10.2337/dci19-0062 · Cited by 306
New insulin delivery recommendations
Frid, A. H., Kreugel, G., Grassi, G., Halimi, S., Hicks, D., Hirsch, L. J., Smith, M. J., Wellhoener, R., Bode, B. W., Hirsch, I. B., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.06.010 · Cited by 286
Korytkowski, M., Bell, D., Jacobsen, C., Suwannasari, R., & FlexPen® Study Team (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80337-5 · Cited by 267
Charleer, S., De Block, C., Van Huffel, L., Broos, B., Fieuws, S., Nobels, F., Mathieu, C., & Gillard, P. (2020) · Diabetes Care · doi:10.2337/dc19-1610 · Cited by 261
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
Umpierrez, G. E., & Klonoff, D. C. (2018) · Diabetes Care · doi:10.2337/dci18-0002 · Cited by 251
Peters, A. L., Ahmann, A. J., Battelino, T., Evert, A., Hirsch, I. B., Murad, M. H., Winter, W. E., & Wolpert, H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2534 · Cited by 250
Forlenza, G. P., Li, Z., Buckingham, B. A., Pinsker, J. E., Cengiz, E., Wadwa, R. P., Ekhlaspour, L., Church, M. M., Weinzimer, S. A., Jost, E., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0771 · Cited by 246 · cited 1×
“cemia during a 6-week randomized crossover trial (185).”
BackgroundReddy, M., Jugnee, N., El Laboudi, A., Spanudakis, E., Anantharaja, S., & Oliver, N. (2018) · Diabetic Medicine · doi:10.1111/dme.13561 · Cited by 245 · cited 1×
“In two of the studies, the primary outcome was a reduction in time spent in hypoglycemia, and rtCGM showed benefit compared with isCGM (76,77).”
ResultYoo, H. J., An, H. G., Park, S. Y., Ryu, O. H., Kim, H. Y., Seo, J. A., Hong, E. G., Shin, D. H., Kim, Y. H., Kim, S. G., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.015 · Cited by 244 · cited 1×
“RCT data on rtCGM use in individuals with type 2 diabetes on MDI (58), mixed therapies (59,60), and basal insulin (61,62) have consistently shown reductions in A1C but not a reduction in rates of hypoglycemia.”
Methodfor the T1D Exchange Clinic Network, T. D. I., Sherr, J. L., Hermann, J. M., Campbell, F., Foster, N. C., Hofer, S. E., Allgrove, J., Maahs, D. M., Kapellen, T. M., Holman, N., et al. (2016) · Diabetologia · doi:10.1007/s00125-015-3790-6 · Cited by 237
Weintrob, N., Benzaquen, H., Galatzer, A., Shalitin, S., Lazar, L., Fayman, G., Lilos, P., Dickerman, Z., & Phillip, M. (2003) · Pediatrics · doi:10.1542/peds.112.3.559 · Cited by 236
Reznik, Y., Cohen, O., Aronson, R., Conget, I., Runzis, S., Castaneda, J., & Lee, S. W. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61037-0 · Cited by 233
Maahs, D. M., Hermann, J. M., Holman, N., Foster, N. C., Kapellen, T. M., Allgrove, J., Schatz, D. A., Hofer, S. E., Campbell, F., Steigleder-Schweiger, C., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0780 · Cited by 224
Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes
Plotnick, L. P., Clark, L. M., Brancati, F. L., & Erlinger, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1142 · Cited by 216
One year clinical experience of the first commercial hybrid closed-loop system
Lal, R. A., Basina, M., Maahs, D. M., Hood, K., Buckingham, B., & Wilson, D. M. (2019) · Diabetes Care · doi:10.2337/dc19-0855 · Cited by 215
The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With Diabetes
Secher, A. L., Ringholm, L., Andersen, H. U., Damm, P., & Mathiesen, E. R. (2013) · Diabetes Care · doi:10.2337/dc12-2360 · Cited by 214 · cited 1×
“Two studies employing intermittent use of rtCGM showed no difference in neonatal outcomes in women with type 1 diabetes (85) or gestational diabetes mellitus (86).”
BackgroundO’Connell, M. A., Donath, S., O’Neal, D. N., Colman, P. G., Ambler, G. R., Jones, T. W., Davis, E. A., & Cameron, F. J. (2009) · Diabetologia · doi:10.1007/s00125-009-1365-0 · Cited by 211
Yaron, M., Roitman, E., Aharon-Hananel, G., Landau, Z., Ganz, T., Yanuv, I., Rozenberg, A., Karp, M., Ish-Shalom, M., Singer, J., et al. (2019) · Diabetes Care · doi:10.2337/dc18-0166 · Cited by 211
Kristensen, K., Ögge, L. E., Sengpiel, V., Kjölhede, K., Dotevall, A., Elfvin, A., Knop, F. K., Wiberg, N., Katsarou, A., Shaat, N., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4850-0 · Cited by 210
Simon, J., Gray, A., Clarke, P., Wade, A., Neil, A., & Farmer, A. (2008) · BMJ · doi:10.1136/bmj.39526.674873.be · Cited by 206
Smartphone apps for calculating insulin dose: a systematic assessment
Huckvale, K., Adomaviciute, S., Prieto, J. T., Leow, M. K.-S., & Car, J. (2015) · BMC Medicine · doi:10.1186/s12916-015-0314-7 · Cited by 202
Ehrhardt, N. M., Chellappa, M., Walker, M. S., Fonda, S. J., & Vigersky, R. A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500320 · Cited by 199 · cited 3×
“RCT data on rtCGM use in individuals with type 2 diabetes on MDI (58), mixed therapies (59,60), and basal insulin (61,62) have consistently shown reductions in A1C but not a reduction in rates of hypoglycemia.”
BackgroundMethodHerman, A., Aerts, O., Baeck, M., Bruze, M., De Block, C., Goossens, A., Hamnerius, N., Huygens, S., Maiter, D., Tennstedt, D., et al. (2017) · Contact Dermatitis · doi:10.1111/cod.12866 · Cited by 192
Karter, A. J., Parker, M. M., Moffet, H. H., Gilliam, L. K., & Dlott, R. (2021) · JAMA · doi:10.1001/jama.2021.6530 · Cited by 191
Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes
Forlenza, G. P., Pinhas-Hamiel, O., Liljenquist, D. R., Shulman, D. I., Bailey, T. S., Bode, B. W., Wood, M. A., Buckingham, B. A., Kaiserman, K. B., Shin, J., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0264 · Cited by 182
Deshmukh, H., Wilmot, E. G., Gregory, R., Barnes, D., Narendran, P., Saunders, S., Furlong, N., Kamaruddin, S., Banatwalla, R., Herring, R., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0738 · Cited by 175
Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline
Galindo, R. J., Umpierrez, G. E., Rushakoff, R. J., Basu, A., Lohnes, S., Nichols, J. H., Spanakis, E. K., Espinoza, J., Palermo, N. E., Awadjie, D. G., et al. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820954163 · Cited by 170
Tyndall, V., Stimson, R. H., Zammitt, N. N., Ritchie, S. A., McKnight, J. A., Dover, A. R., & Gibb, F. W. (2019) · Diabetologia · doi:10.1007/s00125-019-4894-1 · Cited by 165 · cited 1×
“In a retrospective study of adults with type 2 diabetes taking insulin, a reduction in acute diabetes-related events and all-cause hospitalizations was seen (74).”
BackgroundVisser, M. M., Charleer, S., Fieuws, S., De Block, C., Hilbrands, R., Van Huffel, L., Maes, T., Vanhaverbeke, G., Dirinck, E., Myngheer, N., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00789-3 · Cited by 165
Barnard, K. D., Wysocki, T., Allen, J. M., Elleri, D., Thabit, H., Leelarathna, L., Gulati, A., Nodale, M., Dunger, D. B., Tinati, T., et al. (2014) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000025 · Cited by 159
Wada, E., Onoue, T., Kobayashi, T., Handa, T., Hayase, A., Ito, M., Furukawa, M., Okuji, T., Okada, N., Iwama, S., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001115 · Cited by 157 · cited 2×
“Both early (59) and late improvements in A1C were found (59,89).”
BackgroundGalindo, R. J., Aleppo, G., Klonoff, D. C., Spanakis, E. K., Agarwal, S., Vellanki, P., Olson, D. E., Umpierrez, G. E., Davis, G. M., & Pasquel, F. J. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820932903 · Cited by 155 · cited 1×
“Studies are underway to assess the effectiveness of this approach, which may ultimately lead to the routine use of CGM for monitoring hospitalized patients (223,224).”
BackgroundYoung, L. A., Buse, J. B., Weaver, M. A., Vu, M. B., Mitchell, C. M., Blakeney, T., Grimm, K., Rees, J., Niblock, F., Donahue, K. E., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.1233 · Cited by 148
Yang, Y., Lee, E. Y., Kim, H.-S., Lee, S.-H., Yoon, K.-H., & Cho, J.-H. (2020) · JMIR mHealth and uHealth · doi:10.2196/16266 · Cited by 148
History and Perspective on DIY Closed Looping
Lewis, D. M. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818808307 · Cited by 146
Hásková, A., Radovnická, L., Petruželková, L., Parkin, C. G., Grunberger, G., Horová, E., Navrátilová, V., Kádě, O., Matoulek, M., Prázný, M., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0112 · Cited by 146
Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors
Klonoff, D. C., Parkes, J. L., Kovatchev, B. P., Kerr, D., Bevier, W. C., Brazg, R. L., Christiansen, M., Bailey, T. S., Nichols, J. H., & Kohn, M. A. (2018) · Diabetes Care · doi:10.2337/dc17-1960 · Cited by 144
Sepah, S. C., Jiang, L., & Peters, A. L. (2014) · The Diabetes Educator · doi:10.1177/0145721714531339 · Cited by 139
Continuous glucose monitoring in the intensive care unit during the COVID-19 pandemic
Agarwal, S., Mathew, J., Davis, G. M., Shephardson, A., Levine, A., Louard, R., Urrutia, A., Perez-Guzman, C., Umpierrez, G. E., Peng, L., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2219 · Cited by 138
Phillip, M., Bergenstal, R. M., Close, K. L., Danne, T., Garg, S. K., Heinemann, L., Hirsch, I. B., Kovatchev, B. P., Laffel, L. M., Mohan, V., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0375 · Cited by 135 · cited 1×
“Recommendations for developing and implementing a digital diabetes clinic have been published (201).”
BackgroundSherr, J. L., Cengiz, E., Palerm, C. C., Clark, B., Kurtz, N., Roy, A., Carria, L., Cantwell, M., Tamborlane, W. V., & Weinzimer, S. A. (2013) · Diabetes Care · doi:10.2337/dc13-0010 · Cited by 125 · cited 1×
“glycemia (181) and may have psychosocial benefits (182–184).”
BackgroundFive things physicians and patients should question.
(2013) · PubMed · Cited by 123
Pawaskar, M. D., Camacho, F., Anderson, R. T., Cobden, D., Joshi, A. V., & Balkrishnan, R. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.007 · Cited by 119
Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve Abnormality
Zabeen, B., Craig, M. E., Virk, S. A., Pryke, A., Chan, A. K. F., Cho, Y. H., Benitez‐Aguirre, P., Hing, S. J., & Donaghue, K. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153033 · Cited by 117
Kordonouri, O., Hartmann, R., Remus, K., Bläsig, S., Sadeghian, E., & Danne, T. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00880.x · Cited by 116
Wright, E. E., Kerr, M. S. D., Reyes, I. J., Nabutovsky, Y., & Miller, E. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0069 · Cited by 115
Stone, M. P., Agrawal, P. K., Chen, X., Liu, M., Shin, J., Cordero, T. L., & KAUFMAN, F. R. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0202 · Cited by 114
Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors
REDONDO, M. J., Libman, I. M., Cheng, P., Kollman, C., Tosur, M., Gal, R. L., Bacha, F. F., KLINGENSMITH, G. J., Clements, M. A., REDONDO, M. J., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2335 · Cited by 109
Forlenza, G. P., Ekhlaspour, L., Breton, M., Maahs, D. M., Wadwa, R. P., DeBoer, M., Messer, L. H., Town, M., Pinnata, J., Kruse, G., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0011 · Cited by 109
Lipohypertrophy in Young Patients With Type 1 Diabetes
Kordonouri, O., Lauterborn, R., & Deiss, D. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.634 · Cited by 103
Tumminia, A., Crimi, S., Sciacca, L., Buscema, M., Frittitta, L., Squatrito, S., Vigneri, R., & Tomaselli, L. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2557 · Cited by 100 · cited 1×
“sensor use was an important predictor of A1C lowering for all age-groups (30,31).”
BackgroundWEI, Q., SUN, Z., YANG, Y., YU, H., DING, H., & WANG, S. (2016) · Scientific Reports · doi:10.1038/srep19920 · Cited by 99
Breton, M. D., Patek, S. D., Lv, D., Schertz, E., Robic, J., Pinnata, J., Kollar, L., Barnett, C., Wakeman, C., Oliveri, M., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0079 · Cited by 98
Asarani, N. A. M., Reynolds, A. N., Styles, S. E., de Bock, M. I., & Wheeler, B. J. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819870849 · Cited by 98
Karageorgiou, V., Papaioannou, T., Bellos, I., Alexandraki, K., Tentolouris, N., Stefanadis, C., Chrousos, G. P., & Tousoulis, D. (2018) · Metabolism · doi:10.1016/j.metabol.2018.10.002 · Cited by 95
Strategies to Enhance New CGM Use in Early Childhood (SENCE) Study Group, Laffel, L., Harrington, K., Hanono, A., Naik, N., Ambler-Osborn, L., Schultz, A., DiMeglio, L., Woerne, S., Jolivette, H., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1060 · Cited by 95
Treat-to-target trials: uses, interpretation and review of concepts
Garber, A. J. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12129 · Cited by 94
Davis, G. M., Faulds, E., Walker, T., Vigliotti, D., Rabinovich, M., Hester, J., Peng, L., McLean, B., Hannon, P., Poindexter, N., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2085 · Cited by 94
Sherr, J. L., Buckingham, B. A., Forlenza, G. P., Galderisi, A., Ekhlaspour, L., Wadwa, R. P., Carria, L., Hsu, L., Berget, C., Peyser, T. A., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0286 · Cited by 92
Managing diabetes in preschool children
Sundberg, F., Barnard, K., Cato, A., de Beaufort, C., DiMeglio, L. A., Dooley, G., Hershey, T., Hitchcock, J., Jain, V., Weissberg-Benchell, J., et al. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12554 · Cited by 91
Mannucci, E., Antenore, A., Giorgino, F., & Scavini, M. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817719290 · Cited by 90
Haynes, A., Hermann, J. M., Miller, K. M., Hofer, S. E., Jones, T. W., Beck, R. W., Maahs, D. M., Davis, E. A., Holl, R. W., & for the T1D Exchange, W. A. D. R. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12477 · Cited by 88
Bergenstal, R. M., Johnson, M., Passi, R., Bhargava, A., Young, N., Kruger, D. F., Bashan, E., Bisgaier, S. G., Isaman, D. J. M., & Hodish, I. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30368-x · Cited by 88
New, J. P., Ajjan, R., Pfeiffer, A. F. H., & Freckmann, G. (2015) · Diabetic Medicine · doi:10.1111/dme.12713 · Cited by 86
Allergic contact dermatitis caused by glucose sensors in type 1 diabetes patients
Hyry, H. S. I., Liippo, J. P., & Virtanen, H. M. (2019) · Contact Dermatitis · doi:10.1111/cod.13337 · Cited by 86
Kamann, S., Aerts, O., & Heinemann, L. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818762946 · Cited by 85
Bollyky, J. B., Bravata, D., Yang, J., Williamson, M., & Schneider, J. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3961730 · Cited by 85
The Do-It-Yourself Artificial Pancreas: A Comprehensive Review
Kesavadev, J., Srinivasan, S., Saboo, B., Krishna B, M., & Krishnan, G. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00823-z · Cited by 85
Sadhu, A. R., Serrano, I. A., Xu, J., Nisar, T., Lucier, J., Pandya, A. R., & Patham, B. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820964264 · Cited by 84
Health economics and compliance of vials/syringes versus pen devices: a review of the evidence
Asche, C. V., Shane-McWhorter, L., & Raparla, S. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0180 · Cited by 83
Addala, A., Maahs, D. M., Scheinker, D., Chertow, S., Leverenz, B., & Prahalad, P. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13082 · Cited by 83 · cited 1×
“Interruption of access to CGM is associated with a worsening of outcomes (4); therefore, it is important for individuals on CGM to have consistent access to devices.”
BackgroundChao, D. Y., Lin, T. M., & Ma, W.-Y. (2019) · JMIR Diabetes · doi:10.2196/11017 · Cited by 82
Lin, M. H., Connor, C. G., Ruedy, K. J., Beck, R. W., Kollman, C., Buckingham, B., Redondo, M. J., Schatz, D., Haro, H., Lee, J. M., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0132 · Cited by 81
Evidence-based mHealth chronic disease mobile app intervention design: Development of a framework
Wilhide III, C. C., Peeples, M. M., & Anthony Kouyaté, R. C. (2016) · JMIR Research Protocols · doi:10.2196/resprot.4838 · Cited by 81
A virtual type 2 diabetes clinic using continuous glucose monitoring and endocrinology visits
Dixon, R. F., Zisser, H., Layne, J. E., Barleen, N. A., Miller, D. P., Moloney, D. P., Majithia, A. R., Gabbay, R. A., & Riff, J. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819888662 · Cited by 80
Ajjan, R. A., Jackson, N., & Thomson, S. A. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827456 · Cited by 79 · cited 1×
“Use of Professional and Intermittent Continuous Glucose Monitoring Professional CGM devices, which provide retrospective data, either blinded or unblinded, for analysis, can be used to identify patterns of hypo- and hyperglycemia (87,88).”
BackgroundTranslating HbA1c measurements into estimated average glucose values in pregnant women with diabetes
Law, G. R., Gilthorpe, M. S., Secher, A. L., Temple, R., Bilous, R., Mathiesen, E. R., Murphy, H. R., & Scott, E. M. (2017) · Diabetologia · doi:10.1007/s00125-017-4205-7 · Cited by 77
Price, D. A., Deng, Q., Kipnes, M., & Beck, S. E. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01086-y · Cited by 77 · cited 1×
“RCT data on rtCGM use in individuals with type 2 diabetes on MDI (58), mixed therapies (59,60), and basal insulin (61,62) have consistently shown reductions in A1C but not a reduction in rates of hypoglycemia.”
MethodCommissariat, P. V., Boyle, C. T., Miller, K. M., Mantravadi, M. G., DeSalvo, D. J., Tamborlane, W. V., Van Name, M. A., Anderson, B. J., DiMeglio, L. A., & Laffel, L. M. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0375 · Cited by 76
Ekhlaspour, L., Forlenza, G. P., Chernavvsky, D., Maahs, D. M., Wadwa, R. P., Deboer, M. D., Messer, L. H., Town, M., Pinnata, J., Kruse, G., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12867 · Cited by 76
Malanda, U., Bot, S., & Nijpels, G. (2013) · Rivm (National Institute for Public Health and the Environment) · doi:10.2337/dc12-0831document · Cited by 74
Evaluation of Pump Discontinuation and Associated Factors in the T1D Exchange Clinic Registry
Wong, J. C., Boyle, C., DiMeglio, L. A., Mastrandrea, L. D., Abel, K.-L., Cengiz, E., Cemeroglu, P. A., Aleppo, G., Largay, J. F., Foster, N. C., et al. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816663963 · Cited by 69
Brazg, R. L., Klaff, L. J., & Parkin, C. G. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700117 · Cited by 68
Petruzelkova, L., Soupal, J., Plasova, V., Jiranova, P., Neuman, V., Plachy, L., Pruhova, S., Sumnik, Z., & Obermannova, B. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0214 · Cited by 68
Anderson, S. M., Buckingham, B. A., Breton, M. D., Robic, J. L., Barnett, C. L., Wakeman, C. A., Oliveri, M. C., Brown, S. A., Ly, T. T., Clinton, P. K., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0018 · Cited by 68
Factors Related to Discontinuation of Continuous Subcutaneous Insulin-Infusion Therapy
Guinn, T. S., Bailey, G. J., & Mecklenburg, R. S. (1988) · Diabetes Care · doi:10.2337/diacare.11.1.46 · Cited by 66
Reviewing U.S. connected diabetes care: the newest member of the team
Levine, B. J., Close, K. L., & Gabbay, R. A. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0273 · Cited by 66
Riddlesworth, T., Price, D., Cohen, N., & Beck, R. W. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0281-4 · Cited by 65
Insulin pump-associated adverse events in children and adolescents–a prospective study
Wheeler, B. J., Heels, K., Donaghue, K. C., Reith, D. M., & Ambler, G. R. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0388 · Cited by 64 · cited 1×
“Complications of the pump can be caused by issues with infusion sets (dislodgement, occlusion), which place patients at risk for ketosis and DKA and thus must be recognized and managed early (143).”
BackgroundOpipari-Arrigan, L., Fredericks, E. M., Burkhart, N., Dale, L., Hodge, M., & Foster, C. (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00283.x · Cited by 64 · cited 17×
“Practical aspects of pump therapy initiation include assessment of patient and family readiness, if applicable (although there is no consensus on which factors to consider in adults [140] or pediatric patients), selection of pump type and initial pump settings, patient/family education on potential pump complications…”
BackgroundInfluentialAlemzadeh, R., Ellis, J. N., Holzum, M. K., Parton, E. A., & Wyatt, D. T. (2004) · Pediatrics · doi:10.1542/peds.114.1.e91 · Cited by 63
Lasalvia, P., Barahona-Correa, J. E., Romero-Alvernia, D. M., Gil-Tamayo, S., Castañeda-Cardona, C., Bayona, J. G., Triana, J. J., Laserna, A. F., Mejía-Torres, M., Restrepo-Jimenez, P., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816633721 · Cited by 63
What Can We Learn from Patient-Reported Outcomes of Insulin Pen Devices?
Anderson, B. J., & Redondo, M. J. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500633 · Cited by 62
Comparative Device Assessments
Ignaut, D. A., Schwartz, S. L., Sarwat, S., & Murphy, H. L. (2009) · The Diabetes Educator · doi:10.1177/0145721709340056 · Cited by 62
Nathanson, D., Svensson, A.-M., Miftaraj, M., Franzén, S., Bolinder, J., & Eeg-Olofsson, K. (2021) · Diabetologia · doi:10.1007/s00125-021-05437-z · Cited by 61 · cited 2×
“Reductions in acute diabetes complications, such as diabetic ketoacidosis (DKA) and episodes of severe hypoglycemia, have been seen (35,70).”
BackgroundRedondo, M. J., Connor, C. G., Ruedy, K. J., Beck, R. W., Kollman, C., Wood, J. R., Buckingham, B., Klingensmith, G. J., Silverstein, J., Tamborlane, W. V., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12061 · Cited by 60
A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice
Bailey, T. S., & Stone, J. Y. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1313831 · Cited by 60
Beato-Víbora, P. I., Quirós-López, C., Lázaro-Martín, L., Martín-Frías, M., Barrio-Castellanos, R., Gil-Poch, E., Arroyo-Díez, F. J., & Giménez-Álvarez, M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0199 · Cited by 60
Randomized Controlled Trial of Mobile Closed-Loop Control
Kovatchev, B., Anderson, S. M., Raghinaru, D., Kudva, Y. C., Laffel, L. M., Levy, C., Pinsker, J. E., Wadwa, R. P., Buckingham, B., Doyle, F. J., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1310 · Cited by 60
Continuous glucose monitoring pilot in low-income type 1 diabetes patients
Sequeira, P. A., Montoya, L., Ruelas, V., Xing, D., Chen, V., Beck, R., & Peters, A. L. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0072 · Cited by 59
Berghaeuser, M., Kapellen, T., Heidtmann, B., Haberland, H., Klinkert, C., Holl, R., & for the DPV-Science-Initiative and the German working group for insulin pump treatment in paediatric patients (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00416.x · Cited by 58
Rigo, R. S., Levin, L. E., Belsito, D. V., Garzon, M. C., Gandica, R., & Williams, K. M. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820918894 · Cited by 58
The Evidence Base for Diabetes Technology: Appropriate and Inappropriate Meta-Analysis
Pickup, J. C. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700617 · Cited by 56
Patton, S. R., Noser, A. E., Youngkin, E. M., Majidi, S., & Clements, M. A. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0026 · Cited by 56
Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial
Brown, S. A., Beck, R. W., Raghinaru, D., Buckingham, B. A., Laffel, L. M., Wadwa, R. P., Kudva, Y. C., Levy, C. J., Pinsker, J. E., Dassau, E., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0124 · Cited by 55
Shen, Y., Wang, F., Zhang, X., Zhu, X., Sun, Q., Fisher, E., & Sun, X. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9133 · Cited by 54
Wong, J. C., Dolan, L. M., Yang, T. T., & Hood, K. K. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12221 · Cited by 53
Birkebæk, N., Drivvoll, A., Aakesson, K., Bjarnason, R. G., Johansen, A., Samuelsson, U., Skrivarhaug, T., Þórsson, Á. V., & Svensson, J. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000377 · Cited by 53
Boucher, S. E., Gray, A. R., Wiltshire, E. J., de Bock, M. I., Galland, B. C., Tomlinson, P. A., Rayns, J. A., MacKenzie, K. E., Chan, H., Rose, S., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0613 · Cited by 51
Gellad, W. F., Zhao, X., Thorpe, C. T., Mor, M. K., Good, C. B., & Fine, M. J. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.5405 · Cited by 50
Elliott, T., Beca, S., Beharry, R., Tsoukas, M. A., Zarruk, A., & Abitbol, A. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/14791641211021374 · Cited by 49
Psychosocial impact of the bionic pancreas during summer camp
Weissberg-Benchell, J., Hessler, D., Polonsky, W. H., & Fisher, L. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816640289 · Cited by 47
Buckingham, B. A., Christiansen, M. P., Forlenza, G. P., Wadwa, R. P., Peyser, T. A., Lee, J. B., O'Connor, J., Dassau, E., Huyett, L. M., Layne, J. E., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0138 · Cited by 47
Pleus, S., Ulbrich, S., Zschornack, E., Kamann, S., Haug, C., & Freckmann, G. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0171 · Cited by 47
CGM Initiation Soon After Type 1 Diabetes Diagnosis Results in Sustained CGM Use and Wear Time
Prahalad, P., Addala, A., Scheinker, D., Hood, K. K., & Maahs, D. M. (2020) · Diabetes Care · doi:10.2337/dc19-1205 · Cited by 46
Self-monitoring diabetes with multiple mobile health devices
Shaw, R. J., Yang, Q., Barnes, A., Hatch, D., Crowley, M. J., Vorderstrasse, A., Vaughn, J., Diane, A., Lewinski, A. A., Jiang, M., et al. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa007 · Cited by 46
Yeh, T., Yeung, M., & Mendelsohn Curanaj, F. A. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01375-7 · Cited by 46
Deiss, D., Irace, C., Carlson, G., Tweden, K. S., & Kaufman, F. R. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0159 · Cited by 44
Dosing Accuracy of Insulin Pens Versus Conventional Syringes and Vials
Luijf, Y. M., & DeVries, J. H. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0178 · Cited by 43
Vigersky, R. A., Huang, S., Cordero, T. L., Shin, J., Lee, S. W., Chhabra, H., Kaufman, F. R., & Cohen, O. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0234 · Cited by 43
Sandig, D., Grimsmann, J., Reinauer, C., Melmer, A., Zimny, S., Müller-Korbsch, M., Forestier, N., Zeyfang, A., Bramlage, P., Danne, T., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0019 · Cited by 43
Hohendorff, J., Gumprecht, J., Mysliwiec, M., Zozulinska-Ziolkiewicz, D., & Malecki, M. T. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0034 · Cited by 43
Appearance of Do‐It‐Yourself closed‐loop systems to manage type 1 diabetes
Hng, T., & Burren, D. (2018) · Internal Medicine Journal · doi:10.1111/imj.14105 · Cited by 42
Slabaugh, S. L., Bouchard, J. R., Li, Y., Baltz, J. C., Meah, Y. A., & Moretz, D. C. (2015) · Advances in Therapy · doi:10.1007/s12325-015-0266-5 · Cited by 41
Öberg, U., Isaksson, U., Jutterström, L., Orre, C. J., & Hörnsten, Å. (2018) · JMIR Diabetes · doi:10.2196/diabetes.9059 · Cited by 41
Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor
Sanchez, P., Ghosh-Dastidar, S., Tweden, K. S., & Kaufman, F. R. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0234 · Cited by 40 · cited 1×
“In some instances, use of an implanted sensor can help avoid skin reactions in those who are sensitive to tape (104,105).”
BackgroundOppel, E. M., Kamann, S., Heinemann, L., Reichl, F., & Högg, C. (2019) · Contact Dermatitis · doi:10.1111/cod.13392 · Cited by 40
Ushigome, E., Yamazaki, M., Hamaguchi, M., Ito, T., Matsubara, S., Tsuchido, Y., Kasamatsu, Y., Nakanishi, M., Fujita, N., & Fukui, M. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0237 · Cited by 40 · cited 1×
“Studies are underway to assess the effectiveness of this approach, which may ultimately lead to the routine use of CGM for monitoring hospitalized patients (223,224).”
BackgroundAhmann, A., Szeinbach, S. L., Gill, J., Traylor, L., & Garg, S. K. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0172 · Cited by 39
Hermanns, N., Schumann, B., Kulzer, B., & Haak, T. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814524105 · Cited by 39
Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue
Lombardo, F., Salzano, G., Crisafulli, G., Panasiti, I., Alibrandi, A., Messina, M. F., Pajno, G. B., Caminiti, L., & Passanisi, S. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108089 · Cited by 39
Pfützner, A., Schipper, C., Niemeyer, M., Qvist, M., Löffler, A., Forst, T., & Musholt, P. B. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600423 · Cited by 37
Insulin Pump Therapy from the Time of Diagnosis of Type 1 Diabetes
Ramchandani, N., Ten, S., Anhalt, H., Sinha, S., Ching, J., Finkelstein, A., & Maclaren, N. K. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.663 · Cited by 37
Patients who self-monitor blood glucose and their unused testing results.
Grant, R. W., Huang, E. S., Wexler, D. J., Laiteerapong, N., Warton, E. M., Moffet, H. H., & Karter, A. J. (2015) · PubMed · Cited by 37
A review of blood glucose monitor accuracy
King, F., Ahn, D., Hsiao, V., Porco, T., & Klonoff, D. C. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0232 · Cited by 37
Bergenstal, R. M., Peyrot, M., Dreon, D. M., Aroda, V. R., Bailey, T. S., Brazg, R. L., Frias, J. P., Johnson, M. L., Klonoff, D. C., Kruger, D. F., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0298 · Cited by 37
Effect of Professional CGM (pCGM) on Glucose Management in Type 2 Diabetes Patients in Primary Care
Simonson, G. D., Bergenstal, R. M., Johnson, M. L., Davidson, J. L., & Martens, T. W. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821998724 · Cited by 37
App-Based Insulin Calculators: Current and Future State
Eiland, L. A., McLarney, M., Thangavelu, T., & Drincic, A. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1097-y · Cited by 36
Herman, A., de Montjoye, L., & Baeck, M. (2020) · Contact Dermatitis · doi:10.1111/cod.13529 · Cited by 36
Leahy, J. (. L., Aleppo, G., Fonseca, V. A., Garg, S. K., Hirsch, I. B., McCall, A. L., McGill, J. B., & Polonsky, W. H. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00222 · Cited by 34
Troncone, A., Bonfanti, R., Iafusco, D., Rabbone, I., Sabbion, A., Schiaffini, R., Galderisi, A., Marigliano, M., Rapini, N., Rigamonti, A., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1073 · Cited by 33
Insulin delivery by injection in children and adolescents with diabetes
Hanas, R., de Beaufort, C., Hoey, H., & Anderson, B. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00731.x · Cited by 32
Renard, E., Tubiana‐Rufi, N., Bonnemaison‐Gilbert, E., Coutant, R., Dalla‐Vale, F., Farret, A., Poidvin, A., Bouhours‐Nouet, N., Abettan, C., Storey‐London, C., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13482 · Cited by 31
Davis, T. M. E., Dwyer, P., England, M., Fegan, P. G., & Davis, W. A. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0331 · Cited by 31 · cited 1×
“In a study of individuals with type 1 or type 2 diabetes taking insulin, the primary outcome of a reduction in severe hypoglycemia was not met (65).”
BackgroundWinter, A., Lintner, M., & Knezevich, E. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815580361 · Cited by 30
Layne, J. E., Parkin, C. G., & Zisser, H. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816653143 · Cited by 30
Wood, M. A., Shulman, D. I., Forlenza, G. P., Bode, B. W., Pinhas-Hamiel, O., Buckingham, B. A., Kaiserman, K. B., Liljenquist, D. R., Bailey, T. S., Shin, J., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0209 · Cited by 30
Wong, J. C., Izadi, Z., Schroeder, S., Nader, M., Min, J., Neinstein, A. B., & Adi, S. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0251 · Cited by 29
Grunberger, G., Sze, D., Ermakova, A., Sieradzan, R., Oliveria, T., & Miller, E. M. (2020) · Clinical Diabetes · doi:10.2337/cd19-0008 · Cited by 28
Broos, B., Charleer, S., Bolsens, N., Moyson, C., Mathieu, C., Gillard, P., & De Block, C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab188 · Cited by 28 · cited 1×
“Patients with more education regarding device use have better outcomes (1); therefore, the need for additional education should be periodically assessed, particularly if outcomes are not being met.”
BackgroundMcGill, D. E., Volkening, L. K., Butler, D. A., Wasserman, R. M., Anderson, B. J., & Laffel, L. M. (2019) · Diabetic Medicine · doi:10.1111/dme.13929 · Cited by 27
Ulrich, H., & Bowen, M. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.05.013 · Cited by 27
Lameijer, A., Lommerde, N., Dunn, T. C., Fokkert, M. J., Edens, M. A., Kao, K., Xu, Y., Gans, R. O. B., Bilo, H. J. G., & van Dijk, P. R. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108897 · Cited by 27
Meta-analysis: Self-monitoring in non–insulin-treated type 2 diabetes improved HbA1c by 0.25%
Willett, L. R. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-12-201206190-02012 · Cited by 26
Urakami, T., Yoshida, K., Kuwabara, R., Mine, Y., Aoki, M., Suzuki, J., & Morioka, I. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13618 · Cited by 26
Gomez-Peralta, F., Abreu, C., Gomez-Rodriguez, S., Cruz-Bravo, M., María-Sanchez, C., Poza, G., & Ruiz-Valdepeñas, L. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0427 · Cited by 25
Fantasia, K. L., Stockman, M.-C., Ju, Z., Ortega, P., Crable, E. L., Drainoni, M.-L., Walkey, A. J., Bergstrom, M., O'Brien, K., & Steenkamp, D. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100254 · Cited by 25
Research works printed but not linked: 1
- Chandran, 2015, Adherence to insulin pen therapy is associated with reduction in healthcare costs among patients with type 2 diabetes mellitus, Am Health Drug Benefits, 8, 148
Cited by
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05787-2 · Cited by 1,048
de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, P., & Bakris, G. (2022) · Diabetes Care · doi:10.2337/dci22-0027 · Cited by 919
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Battelino, T., Alexander, C. M., Amiel, S. A., Arreaza-Rubin, G., Beck, R. W., Bergenstal, R. M., Buckingham, B. A., Carroll, J., Ceriello, A., Chow, E., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00319-9 · Cited by 831
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Metadata
- Authors
- American Diabetes Association Professional Practice Committee
- Corresponding author
- American Diabetes Association Professional Practice Committee
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-12-16
- Volume
- 45
- Issue
- Supplement_1
- Pages
- S97-S112
- ISSN
- 0149-5992 (ISSN-L)
- OpenAlex
- W4200316649
- Semantic Scholar
- 485b3c0c22c51827fd245d87ab7936a39cae732b
- Cited by
- 358
- References
- 225
- Citations by year
- 2026: 21 · 2025: 34 · 2024: 49 · 2023: 106 · 2022: 98 · 2021: 27
- FWCI
- 10.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- diabetes technology, clinical guidelines, treatment goals, quality of care, diabetes management
- MeSH terms
- Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.